[go: up one dir, main page]

NO20050019L - Polytylenglykolaldehyd-derivater - Google Patents

Polytylenglykolaldehyd-derivater

Info

Publication number
NO20050019L
NO20050019L NO20050019A NO20050019A NO20050019L NO 20050019 L NO20050019 L NO 20050019L NO 20050019 A NO20050019 A NO 20050019A NO 20050019 A NO20050019 A NO 20050019A NO 20050019 L NO20050019 L NO 20050019L
Authority
NO
Norway
Prior art keywords
polytylenglykolaldehyd
derivatives
compounds
preparation
methods
Prior art date
Application number
NO20050019A
Other languages
English (en)
Other versions
NO336974B1 (no
Inventor
Chee-Youb Won
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20050019L publication Critical patent/NO20050019L/no
Publication of NO336974B1 publication Critical patent/NO336974B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/321—Polymers modified by chemical after-treatment with inorganic compounds
    • C08G65/324—Polymers modified by chemical after-treatment with inorganic compounds containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2603—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
    • C08G65/2615—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen the other compounds containing carboxylic acid, ester or anhydride groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2618—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing nitrogen
    • C08G65/2621—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing nitrogen containing amine groups
    • C08G65/2624—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing nitrogen containing amine groups containing aliphatic amine groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Polyetylenglykolaldehydforbindelser blir tilveiebrakt. Fremgangsmåter for fremstilling og anvendelse av slike forbindelser, så vel som kjemiske mellomprodukter blir også tilveiebrakt.
NO20050019A 2002-07-24 2005-01-03 Polyetylenglykolaldehyd-derivater samt fremgangsmåte for fremstilling av slike NO336974B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39819602P 2002-07-24 2002-07-24
PCT/EP2003/007734 WO2004013205A1 (en) 2002-07-24 2003-07-16 Polyethylene glycol aldehyde derivatives

Publications (2)

Publication Number Publication Date
NO20050019L true NO20050019L (no) 2005-02-23
NO336974B1 NO336974B1 (no) 2015-12-07

Family

ID=31495721

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050019A NO336974B1 (no) 2002-07-24 2005-01-03 Polyetylenglykolaldehyd-derivater samt fremgangsmåte for fremstilling av slike

Country Status (28)

Country Link
US (2) US7273909B2 (no)
EP (1) EP1539857B1 (no)
JP (1) JP4071238B2 (no)
KR (1) KR100615753B1 (no)
CN (1) CN1671769B (no)
AR (1) AR040607A1 (no)
AT (1) ATE344289T1 (no)
AU (1) AU2003250971B2 (no)
BR (1) BR0312863B1 (no)
CA (1) CA2493221C (no)
DE (1) DE60309482T2 (no)
DK (1) DK1539857T3 (no)
ES (1) ES2274277T3 (no)
GT (1) GT200300154A (no)
HR (1) HRP20050026A2 (no)
IL (1) IL165920A0 (no)
JO (1) JO2400B1 (no)
MX (1) MXPA05000799A (no)
NO (1) NO336974B1 (no)
PA (1) PA8577601A1 (no)
PE (1) PE20040703A1 (no)
PL (1) PL214871B1 (no)
PT (1) PT1539857E (no)
RU (1) RU2288212C2 (no)
TW (1) TWI276647B (no)
UY (1) UY27902A1 (no)
WO (1) WO2004013205A1 (no)
ZA (1) ZA200410296B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4959133B2 (ja) 2002-09-09 2012-06-20 ネクター セラピューティックス 末端カルボン酸またはそのエステルを有する水溶性ポリマー誘導体の調製方法
AU2003270454B2 (en) * 2002-09-09 2010-05-20 Nektar Therapeutics Water-soluble polymer alkanals
US20050214250A1 (en) * 2003-11-06 2005-09-29 Harris J M Method of preparing carboxylic acid functionalized polymers
US7989554B2 (en) * 2006-01-10 2011-08-02 Enzon Pharmaceuticals, Inc. Reacting polyalkylene oxide with base, tertiary alkyl haloacetate, then acid to prepare polyalkylene oxide carboxylic acid
WO2008051383A2 (en) * 2006-10-19 2008-05-02 Amgen Inc. Use of alcohol co-solvents to improve pegylation reaction yields
WO2008048079A1 (en) * 2006-10-20 2008-04-24 Postech Academy-Industry Foundation Long acting formulation of biopharmaceutical
US8247493B2 (en) * 2007-10-22 2012-08-21 Postech Academy-Industry Foundation Long acting formulation of biopharmaceutical
KR100967833B1 (ko) * 2008-05-20 2010-07-05 아이디비켐(주) 고순도의 폴리에틸렌글리콜 알데하이드 유도체의 제조방법
JP5766118B2 (ja) * 2008-09-11 2015-08-19 ウェルズ ファーゴ バンク ナショナル アソシエイション ポリマー性アルファ−ヒドロキシアルデヒドおよびケトン反応剤ならびに抱合方法
RU2439091C1 (ru) * 2010-10-06 2012-01-10 Общество С Ограниченной Ответственностью "Форт" (Ооо "Форт") Производные полиэтиленгликоля, содержащие ароматическую диазогруппу
EP2592103A1 (en) 2011-11-08 2013-05-15 Adriacell S.p.A. Polymer aldehyde derivatives
KR101641206B1 (ko) * 2013-06-24 2016-07-22 에이비엘바이오 주식회사 안정성이 개선된 항체-약물 결합체 및 이의 용도
TWI689310B (zh) * 2014-07-11 2020-04-01 巨生生醫股份有限公司 治療鐵缺乏症之方法
KR102247701B1 (ko) 2016-02-26 2021-05-03 한미정밀화학주식회사 폴리에틸렌글리콜 디알데히드 유도체의 제조방법
US11603346B2 (en) 2016-03-07 2023-03-14 Hanmi Pharm. Co., Ltd. Polyethylene glycol derivative and use thereof
EP3689942B1 (en) * 2017-09-29 2024-06-19 Hanmi Pharm. Co., Ltd. Protein complex comprising non-peptidyl polymer-coupled fatty acid derivative compound as linker and preparation method therefor
EP4448556A1 (en) 2021-12-16 2024-10-23 RDP Pharma AG Cell penetrating polypeptides (cpps) and their use in human therapy
EP4480497A1 (en) 2023-06-21 2024-12-25 RDP Pharma AG Bio-conjugates for oncology

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5770577A (en) * 1994-11-14 1998-06-23 Amgen Inc. BDNF and NT-3 polypeptides selectively linked to polyethylene glycol
CH690143A5 (de) 1995-01-27 2000-05-15 Rieter Automotive Int Ag Lambda/4-Schallabsorber.
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5990237A (en) 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
WO2000024697A1 (en) * 1998-10-26 2000-05-04 University Of Utah Research Foundation Method for preparation of polyethylene glycol aldehyde derivatives
JO2291B1 (en) 1999-07-02 2005-09-12 اف . هوفمان لاروش ايه جي Erythropoietin derivatives
KR100488351B1 (ko) 2001-12-11 2005-05-11 선바이오(주) 신규한 폴리에틸렌글리콜-프로피온알데히드 유도체
EP1507755A4 (en) 2001-12-11 2006-05-17 Sun Bio Inc NOVEL MONOFUNCTIONAL POLYETHYLENE GLYCOL ALDEHYDES

Also Published As

Publication number Publication date
DK1539857T3 (da) 2007-03-12
JP4071238B2 (ja) 2008-04-02
WO2004013205A1 (en) 2004-02-12
AR040607A1 (es) 2005-04-13
CN1671769B (zh) 2010-05-12
UY27902A1 (es) 2003-12-31
BR0312863B1 (pt) 2013-02-05
HRP20050026A2 (en) 2006-02-28
TW200416241A (en) 2004-09-01
EP1539857B1 (en) 2006-11-02
RU2288212C2 (ru) 2006-11-27
IL165920A0 (en) 2006-01-15
TWI276647B (en) 2007-03-21
DE60309482D1 (de) 2006-12-14
ATE344289T1 (de) 2006-11-15
KR100615753B1 (ko) 2006-08-25
AU2003250971B2 (en) 2008-04-03
AU2003250971A1 (en) 2004-02-23
NO336974B1 (no) 2015-12-07
JO2400B1 (en) 2007-06-17
PL214871B1 (pl) 2013-09-30
BR0312863A (pt) 2005-06-14
CN1671769A (zh) 2005-09-21
ES2274277T3 (es) 2007-05-16
PE20040703A1 (es) 2004-10-14
CA2493221A1 (en) 2004-02-12
KR20050025974A (ko) 2005-03-14
EP1539857A1 (en) 2005-06-15
PA8577601A1 (es) 2004-02-07
US20040019157A1 (en) 2004-01-29
DE60309482T2 (de) 2007-06-28
PL375266A1 (en) 2005-11-28
US20070167606A1 (en) 2007-07-19
GT200300154A (es) 2004-03-15
JP2005533913A (ja) 2005-11-10
PT1539857E (pt) 2007-01-31
ZA200410296B (en) 2006-07-26
MXPA05000799A (es) 2005-04-19
RU2005105568A (ru) 2005-10-20
US7273909B2 (en) 2007-09-25
CA2493221C (en) 2008-11-18

Similar Documents

Publication Publication Date Title
NO20053340D0 (no) Substituerte dihydropyrano-indol-3,4-dion-derivater som inhibitorer for plasmigogenaktivator-1 (CPAI-1).
NO20050019L (no) Polytylenglykolaldehyd-derivater
LTPA2014013I1 (lt) Fenilpiperazino dariniai, kaip serotonino grįžtamos absorbcijos inhibitoriai
NO20030374D0 (no) Syklopentanoindoler, preparater som inneholder slike forbindelser og behandlingsfremgangsmåter
NO20052887D0 (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
CY1106468T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
DE602004024770D1 (de) Substituierte 8-perfluoro-6,7,8,9-tetrahydropyrimido-(1,2a) pyrimidin-4-on derivate
IS7755A (is) Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín
ATE430726T1 (de) N-acylamino-benzyletherderivate als selektive inhibitoren der monoaminoxidase b
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
DE60324703D1 (de) Barbitursäure derivaten.
BR0316544A (pt) Compostos calcilìticos
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
NO20061316L (no) Imidazopyndinderivater som induserbare NO-syntaseinhibitorer
NO20061344L (no) Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer
ITTO20030850A1 (it) Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro.
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
DE60321724D1 (de) 1,2-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
DK1521752T3 (da) Makrocykliske forbindelser til behandling af cancer
DK1490363T3 (da) Fremgangsmåder til fremstilling af 2-7-chlor-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)1-isoindolinon
WO2004099129A3 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees